John A Zic

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. ncbi request reprint The treatment of cutaneous T-cell lymphoma with photopheresis
    John A Zic
    Vanderbilt University, Division of Dermatology, Nashville, Tennessee 37232 5227, USA
    Dermatol Ther 16:337-46. 2003
  2. ncbi request reprint Open-label pilot study of combination therapy with rosiglitazone and bexarotene in the treatment of cutaneous T-cell lymphoma
    Jacob A Sepmeyer
    Vanderbilt University School of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232 5227, USA
    J Am Acad Dermatol 56:584-7. 2007
  3. ncbi request reprint Gadolinium deposition in nephrogenic fibrosing dermopathy
    Alan S Boyd
    Department of Medicine Dermatology, Vanderbilt University, Nashville, TN 37232, USA
    J Am Acad Dermatol 56:27-30. 2007
  4. pmc miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma
    Laura Y McGirt
    Department of Medicine Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    J Invest Dermatol 134:1101-7. 2014
  5. doi request reprint Photopheresis in the treatment of cutaneous T-cell lymphoma: current status
    John A Zic
    Division of Dermatology, Vanderbilt University School of Medicine, Nashville, Tennessee 37204, USA
    Curr Opin Oncol 24:S1-10. 2012
  6. ncbi request reprint Controversies in the management of the cutaneous T cell lymphomas
    John A Zic
    Vanderbilt University School of Medicine, Nashville, Tennessee 37232 5227, USA
    Dermatol Ther 22:407-17. 2009
  7. ncbi request reprint Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphoma
    Adriana N Schmidt
    Division of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    J Am Acad Dermatol 54:S202-5. 2006
  8. ncbi request reprint Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a North American series
    Beth L Brogan
    Departments of Medicine, Vanderbilt University Medical School, Nashville, Tennessee 37232 5227, USA
    J Am Acad Dermatol 49:223-8. 2003

Collaborators

Detail Information

Publications8

  1. ncbi request reprint The treatment of cutaneous T-cell lymphoma with photopheresis
    John A Zic
    Vanderbilt University, Division of Dermatology, Nashville, Tennessee 37232 5227, USA
    Dermatol Ther 16:337-46. 2003
    ..Efforts to establish the effectiveness of combining ECP with other newer immunoadjuvant therapies and modifications of the procedure to enhance immunomodulation are exciting prospects for patients with CTCL...
  2. ncbi request reprint Open-label pilot study of combination therapy with rosiglitazone and bexarotene in the treatment of cutaneous T-cell lymphoma
    Jacob A Sepmeyer
    Vanderbilt University School of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232 5227, USA
    J Am Acad Dermatol 56:584-7. 2007
    ..After 16 weeks of combination therapy, skin score decreased in two patients. Pruritus was alleviated in 3 of 4 patients, whereas quality of life was unchanged. Adverse events included hyperlipidemia, anemia, neutropenia, and lymphopenia...
  3. ncbi request reprint Gadolinium deposition in nephrogenic fibrosing dermopathy
    Alan S Boyd
    Department of Medicine Dermatology, Vanderbilt University, Nashville, TN 37232, USA
    J Am Acad Dermatol 56:27-30. 2007
    ..The pathogenesis of this entity remains unclear; however, our recent observations suggest a likely mechanism for the initial dermal manifestations of this gadolinium toxicity...
  4. pmc miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma
    Laura Y McGirt
    Department of Medicine Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    J Invest Dermatol 134:1101-7. 2014
    ..Thus, miR-223 and its targets may be useful for the development of new therapeutics for MF/CTCL. ..
  5. doi request reprint Photopheresis in the treatment of cutaneous T-cell lymphoma: current status
    John A Zic
    Division of Dermatology, Vanderbilt University School of Medicine, Nashville, Tennessee 37204, USA
    Curr Opin Oncol 24:S1-10. 2012
    ..In addition, there has been progress in understanding how ECP works at the cellular level...
  6. ncbi request reprint Controversies in the management of the cutaneous T cell lymphomas
    John A Zic
    Vanderbilt University School of Medicine, Nashville, Tennessee 37232 5227, USA
    Dermatol Ther 22:407-17. 2009
    ..When using the systemic agents, a "start low and go slow" strategy may offer patients several advantages. Dermatologists are uniquely trained to diagnose and to manage all but the most advanced stage patients with CTCL...
  7. ncbi request reprint Conjugal transformed mycosis fungoides: the unknown role of viral infection and environmental exposures in the development of cutaneous T-cell lymphoma
    Adriana N Schmidt
    Division of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
    J Am Acad Dermatol 54:S202-5. 2006
    ..Future studies should aim to clarify the potential role of infectious agents, such as human T-lymphotropic virus I and II, cytomegalovirus, Epstein-Barr virus, and other environmental exposures, in the development of MF...
  8. ncbi request reprint Large B-cell lymphoma of the leg: clinical and pathologic characteristics in a North American series
    Beth L Brogan
    Departments of Medicine, Vanderbilt University Medical School, Nashville, Tennessee 37232 5227, USA
    J Am Acad Dermatol 49:223-8. 2003
    ..Large B-cell lymphoma (LBCL) of the leg is an uncommon subset of primary cutaneous B-cell lymphoma that has been described in a series of European patients...